User contributions
Jump to navigation
Jump to search
- 22:52, 6 December 2022 diff hist +4 m Melanoma →Pembrolizumab monotherapy {{#subobject:0a3e71|Regimen=1}}
- 16:30, 6 December 2022 diff hist +104 Melanoma →Pembrolizumab monotherapy {{#subobject:0a3e71|Regimen=1}}
- 16:26, 6 December 2022 diff hist +1,708 Melanoma →Neoadjuvant response criteria
- 14:12, 3 August 2022 diff hist +38 m User:Ryannguyen personal page update current Tag: visualeditor
- 15:23, 3 April 2022 diff hist +359 Melanoma →Nivolumab & Relatlimab {{#subobject:6abj1d|Regimen=1}}
- 15:19, 3 April 2022 diff hist +539 Melanoma →Pembrolizumab monotherapy {{#subobject:0a3e71|Regimen=1}}
- 01:30, 30 January 2022 diff hist +1 m Melanoma →Ipilimumab & Nivolumab {{#subobject:51gu10|Regimen=1}}
- 02:58, 28 January 2022 diff hist +1,886 Melanoma, BRAF-mutated →Advanced or metastatic disease, BRAF inhibitor-naive
- 02:39, 28 January 2022 diff hist +2,493 Uveal melanoma →Metastatic or unresectable disease
- 02:21, 28 January 2022 diff hist +116 Melanoma →Pembrolizumab monotherapy {{#subobject:0a3e71|Regimen=1}}
- 02:16, 28 January 2022 diff hist +644 Melanoma →References
- 02:14, 28 January 2022 diff hist +1,590 Melanoma →Metastatic or unresectable disease, second-line
- 02:01, 28 January 2022 diff hist +1,449 Melanoma →Metastatic or unresectable disease, first-line
- 02:08, 11 July 2021 diff hist +1,489 Esophageal squamous cell carcinoma →Metastatic or locally advanced disease, first-line
- 01:55, 11 July 2021 diff hist +44 Esophageal squamous cell carcinoma →Ipilimumab & Nivolumab {{#subobject:62bagc|Regimen=1}}
- 01:46, 11 July 2021 diff hist 0 m Esophageal squamous cell carcinoma →Cisplatin, Paclitaxel, Camrelizumab {{#subobject:5d50ee|Regimen=1}}
- 01:46, 11 July 2021 diff hist +117 Esophageal squamous cell carcinoma →Cisplatin & Paclitaxel {{#subobject:5d50ee|Regimen=1}}
- 01:44, 11 July 2021 diff hist +116 Esophageal squamous cell carcinoma →Cisplatin, Paclitaxel, Camrelizumab {{#subobject:5d50ee|Regimen=1}}
- 03:50, 26 April 2021 diff hist +3,695 Esophageal adenocarcinoma →Metastatic or locally advanced disease, first-line
- 03:09, 26 April 2021 diff hist +1,838 Colon cancer →Therapy for oligometastatic disease, including perioperative therapy and hyperthermic intra-peritoneal chemotherapy